Voyager Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Voyager Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2014 to Q2 2024.
  • Voyager Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $4.04M, a 51.3% increase year-over-year.
  • Voyager Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $13.5M, a 38.6% increase year-over-year.
  • Voyager Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $11.2M, a 19.4% increase from 2022.
  • Voyager Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.34M, a 17.5% decline from 2021.
  • Voyager Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.3M, a 24.2% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $13.5M $4.04M +$1.37M +51.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $12.2M $3.57M +$1.02M +39.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $11.2M $3.05M +$699K +29.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $10.5M $2.88M +$689K +31.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $9.77M $2.67M +$182K +7.31% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $9.58M $2.56M +$239K +10.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $9.34M $2.35M +$691K +41.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $8.65M $2.19M +$112K +5.39% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $8.54M $2.49M -$1.5M -37.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $10M $2.32M -$1.28M -35.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $11.3M $1.66M -$1.85M -52.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $13.2M $2.08M -$1.46M -41.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $14.6M $3.99M +$132K +3.42% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $14.5M $3.6M -$439K -10.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $14.9M $3.5M -$16K -0.46% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $15M $3.53M +$183K +5.46% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $14.8M $3.86M -$1.4M -26.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $16.2M $4.04M +$522K +14.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $15.6M $3.52M +$881K +33.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 $14.8M $3.35M +$713K +27% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $14M $5.25M -$2.86M -35.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $16.9M $3.52M +$1.2M +51.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $15.7M $2.64M +$344K +15% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $15.4M $2.64M -$605K -18.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $16M $8.11M +$6.58M +428% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $9.4M $2.32M +$157K +7.25% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $9.24M $2.29M +$513K +28.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-03
Q3 2017 $8.73M $3.24M +$1.45M +81.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $7.27M $1.54M +$220K +16.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $7.05M $2.17M +$743K +52.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $6.31M $1.78M -$185K -9.41% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $6.5M $1.79M +$932K +109% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $5.56M $1.32M +$416K +46.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $5.15M $1.42M +$1.12M +371% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $4.03M $1.97M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $857K +$689K +410% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $902K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $302K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 $168K Jul 1, 2014 Sep 30, 2014 10-Q 2015-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.